Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study)
Munoz-Cano, R, Ainsua-Enrich, E, Torres-Atencio, I, Martin, M, Sánchez-Lopez, J, Bartra, J, Picado, C, Mullol, J, Valero, A
Published in Journal of investigational allergology & clinical immunology (01.01.2017)
Published in Journal of investigational allergology & clinical immunology (01.01.2017)
Get full text
Journal Article
Effects Of Rupatadine On Platelet Activating Factor (PAF)-induced Human Mast Cell Degranulation Compared With Desloratadine And Levocetirizine
Munoz-Cano, R, Torres-Atencio, I, Ainsua, E, Martin Andorra, M, Sanchez-Lopez, J, Bartra, J, Picado, C, Valero Santiago, A
Published in Journal of allergy and clinical immunology (01.02.2012)
Published in Journal of allergy and clinical immunology (01.02.2012)
Get full text
Journal Article
Platelet activating factor‐induced mast cell degranulation is inhibited by rupatadine, and to a lower extent by levocetirizine and desoratadine, in a mast cell line (LAD‐2)
Mullol, Joaquim, Muñoz‐Cano, Rosa, Torres‐Atencio, I, Ainsua, E, Martin, M, Sanchez‐Lopez, J, Bartra, Joan, Picado, Cesar, Valero, Antonio
Published in Clinical and translational allergy (16.07.2013)
Published in Clinical and translational allergy (16.07.2013)
Get full text
Journal Article